Orphan designation: Entospletinib Treatment of acute myeloid leukaemia, 16/10/2017 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 June 2025 - 7:23

Orphan designation: Entospletinib Treatment of acute myeloid leukaemia, 16/10/2017 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-17-1922

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters